These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31633557)

  • 1. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
    Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE;
    Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis.
    Mallo SC; Patten SB; Ismail Z; Pereiro AX; Facal D; Otero C; Juncos-Rabadán O
    Ageing Res Rev; 2020 Mar; 58():101004. PubMed ID: 31881368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory - Clinician rating scale (NPI-C).
    Zaidi S; Kat MG; de Jonghe JF
    Int Psychogeriatr; 2014 Jul; 26(7):1139-45. PubMed ID: 24622334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Xu L; Li T; Xiong L; Wang X; Ismail Z; Fukuda M; Sun Z; Wang J; Gauthier S; Yu X; Wang H
    J Alzheimers Dis; 2021; 81(3):1141-1149. PubMed ID: 33935092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.
    Roalf DR; Moberg PJ; Xie SX; Wolk DA; Moelter ST; Arnold SE
    Alzheimers Dement; 2013 Sep; 9(5):529-37. PubMed ID: 23260866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
    Aguilar-Barberà M; Soler-Girabau P; Tabuenca-Martín AI; Prieto-Del Val L
    J Alzheimers Dis; 2023; 93(2):621-631. PubMed ID: 37066911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
    Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
    J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary AD7c-NTP Evaluates Cognition Impairment and Differentially Diagnoses AD and MCI.
    Xu MR; Dai RF; Wei QQ; Wang J; Feng YY; Hu Y
    Am J Alzheimers Dis Other Demen; 2022; 37():15333175221115247. PubMed ID: 35833655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
    Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.